Clinical Trial Update: Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Acridine Carboxamide in patients with recurrent glioblastoma multiforme has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Acridine Carboxamide (Acridine carboxamide)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED